Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib

  • Lilia L Bi1,
  • George Pan6,
  • T Prescott Atkinson7,
  • Lixin Zheng3Email author,
  • Janet K Dale2,
  • Christopher Makris7,
  • Vishnu Reddy6,
  • Jay M McDonald6, 8,
  • Richard M Siegel5,
  • Jennifer M Puck4,
  • Michael J Lenardo3Email author and
  • Stephen E Straus^2
^Deceased
BMC Medical Genetics20078:41

DOI: 10.1186/1471-2350-8-41

Received: 01 December 2006

Accepted: 02 July 2007

Published: 02 July 2007

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
1 Dec 2006 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
25 Jan 2007 Reviewed Reviewer Report - Anke van den Berg
7 Feb 2007 Reviewed Reviewer Report - Austen Worth
9 Apr 2007 Author responded Author comments - Lixin Zheng
Resubmission - Version 3
9 Apr 2007 Submitted Manuscript version 3
3 May 2007 Reviewed Reviewer Report - Anke van den Berg
5 May 2007 Reviewed Reviewer Report - Austen Worth
1 Jun 2007 Author responded Author comments - Lixin Zheng
Resubmission - Version 4
1 Jun 2007 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
20 Jun 2007 Author responded Author comments - Lixin Zheng
Resubmission - Version 6
20 Jun 2007 Submitted Manuscript version 6
Publishing
2 Jul 2007 Editorially accepted
2 Jul 2007 Article published 10.1186/1471-2350-8-41

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Center for Biologics Evaluation and Research, FDA
(2)
Laboratory of Clinical Infectious Diseases, NIAID, NIH
(3)
Laboratory of Immunology, NIAID, NIH
(4)
Department of Pediatrics, University of California
(5)
Autoimmunity Branch, NIAMS, NIH
(6)
Department of Pathology, University of Alabama at Birmingham
(7)
Department of Pediatrics, University of Alabama at Birmingham
(8)
The Birmingham Veteran's Administration Medical Center

Advertisement